<?xml version="1.0" encoding="UTF-8"?>
<p id="Par58">The frequency of report submission to NRAs depends on factors such as the length of time the medicinal product has been on the market, product-specific risks and the extent of knowledge regarding the product’s benefit–risk profile.</p>
